000 | 01903 a2200577 4500 | ||
---|---|---|---|
005 | 20250517112043.0 | ||
264 | 0 | _c20180201 | |
008 | 201802s 0 0 eng d | ||
022 | _a1080-6059 | ||
024 | 7 |
_a10.3201/eid2209.151579 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan der Sanden, Sabine M G | |
245 | 0 | 0 |
_aPrediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands. _h[electronic resource] |
260 |
_bEmerging infectious diseases _c09 2016 |
||
300 |
_a1562-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Neutralizing _xblood |
650 | 0 | 4 |
_aAntibodies, Viral _xblood |
650 | 0 | 4 |
_aCapsid Proteins _xgenetics |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCoinfection |
650 | 0 | 4 |
_aCross Protection _ximmunology |
650 | 0 | 4 | _aDisease Outbreaks |
650 | 0 | 4 |
_aEnterovirus A, Human _xclassification |
650 | 0 | 4 |
_aEnterovirus Infections _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHIV Infections |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNetherlands _xepidemiology |
650 | 0 | 4 | _aNeutralization Tests |
650 | 0 | 4 | _aPopulation Surveillance |
650 | 0 | 4 | _aSeroepidemiologic Studies |
650 | 0 | 4 | _aViral Plaque Assay |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aKoen, Gerrit | |
700 | 1 | _avan Eijk, Hetty | |
700 | 1 | _aKoekkoek, Sylvie M | |
700 | 1 | _ade Jong, Menno D | |
700 | 1 | _aWolthers, Katja C | |
773 | 0 |
_tEmerging infectious diseases _gvol. 22 _gno. 9 _gp. 1562-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3201/eid2209.151579 _zAvailable from publisher's website |
999 |
_c26335737 _d26335737 |